Inventor · disambiguated record
Wei Lu
Also filed as: LU WEI · LU WEI-CHENG
18 granted patents·7 pending applications·50 citations·filing 2010–2022
91Inventor score
Files withUNIV TEXAS10ARBOR BIOTECHNOLOGIES INC4DOWLING PETER C3UNIV NAT TSING HUA2US GOV VETERANS AFFAIRS2
Top patents by PatentIndex Score
25 records- 0193US9975959B2Administration of kynurenine depleting enzymes for tumor therapyUNIV TEXAS·Filed 2015·Granted May 22, 2018·8 cites·16 claims
- 0293US9624484B2Engineered primate L-methioninase for therapeutic purposesUNIV TEXAS·Filed 2016·Granted Apr 18, 2017·11 cites·12 claims
- 0392US9481877B2Engineered primate L-methioninase for therapeutic purposesUNIV TEXAS·Filed 2014·Granted Nov 1, 2016·14 cites·19 claims
- 0491US11168142B2Administration of kynurenine depleting enzymes for tumor therapyUNIV TEXAS·Filed 2018·Granted Nov 9, 2021·5 cites·20 claims
- 0590US10233438B2Engineered primate L-methioninase for therapeutic purposesUNIV TEXAS·Filed 2017·Granted Mar 19, 2019·6 cites·18 claims
- 0683US10724026B2Engineered primate L-methioninase for therapeutic purposesUNIV TEXAS·Filed 2019·Granted Jul 28, 2020·2 cites·17 claims
- 0775US11866746B2Compositions comprising a variant Cas12i4 polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Jan 9, 2024·0 cites·20 claims
- 0875US8790909B2Strains of Helicobacter pylori and uses thereofBENGHEZAL MOHAMMED·Filed 2010·Granted Jul 29, 2014·3 cites·12 claims
- 0973US11946045B2Compositions comprising a variant polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Apr 2, 2024·0 cites·23 claims
- 1070US12036269B2Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuriaUNIV TEXAS·Filed 2021·Granted Jul 16, 2024·0 cites·16 claims
- 1170US9585932B2Use of EPO-derived peptide fragments for the treatment of neurodegenerative disordersDOWLING PETER C·Filed 2013·Granted Mar 7, 2017·1 cites·2 claims
- 1270US2022275099A1Administration of kynurenine depleting enzymes for tumor therapyUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1369US11559565B2Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptidesUS GOV VETERANS AFFAIRS·Filed 2020·Granted Jan 24, 2023·0 cites·7 claims
- 1466US11033612B2Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuriaUNIV TEXAS·Filed 2018·Granted Jun 15, 2021·0 cites·34 claims
- 1565US2018303903A1Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic epo short peptidesDOWLING PETER C·Filed 2018·Application pending·0 cites
- 1663US2024309346A1Compositions comprising a variant cas12i4 polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1761US2024141388A1Compositions comprising a variant polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1860US12163168B2Engineered primate cystine/cysteine degrading enzymes for therapeutic usesUNIV TEXAS·Filed 2019·Granted Dec 10, 2024·0 cites·34 claims
- 1956US10010583B2Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptidesWANG BO·Filed 2016·Granted Jul 3, 2018·0 cites·17 claims
- 2056US2024207361A1Erythropoietin-derived peptides for treating relapsing-remitting multiple sclerosisUS GOV VETERANS AFFAIRS·Filed 2022·Application pending·0 cites
- 2155US9345745B2Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptidesWANG BO·Filed 2011·Granted May 24, 2016·0 cites·13 claims
- 2247US2021252011A1Treatment of glioblastoma with fasn inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2345US2017137483A1Use of epo-derived peptide fragments for the treatment of inflammatory diseasesDOWLING PETER C·Filed 2017·Application pending·0 cites
- 2443US10570425B2Engineered cyanobacterium and its application for producing acetateUNIV NAT TSING HUA·Filed 2017·Granted Feb 25, 2020·0 cites·10 claims
- 2542US10982238B2Escherichia coli transformant for producing itaconate and uses thereofUNIV NAT TSING HUA·Filed 2019·Granted Apr 20, 2021·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Wei Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →